PYNNONEN BRETT D 4
4 · VISTEON CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Visteon (VC) SVP Brett Pynnonen Receives Equity Awards
What Happened
Brett D. Pynnonen, Senior Vice President & Chief Legal Officer of Visteon Corporation, was granted equity awards on March 1, 2026: 7,573 performance rights and 5,049 restricted stock units (RSUs), for a total of 12,622 award units. Both grants are recorded at $0.00 per share on the Form 4 (award/derivative transactions), meaning no cash was exchanged at grant — these are compensation awards, not open-market purchases.
Key Details
- Transaction date: 2026-03-01; Form filed: 2026-03-03 (filed within the typical 2-business-day Form 4 window).
- Awards: 7,573 performance rights (derivative) and 5,049 RSUs (derivative), grant code A (award). Reported price per unit: $0.00.
- Shares owned after transaction: not specified in the provided filing details.
- Footnote F1: Each performance right is a contingent right to one share, vesting based on relative shareholder return and return on invested capital over a three-year performance period; payable in stock and subject to tax withholding.
- Footnote F2: RSUs vest 33% on each March 15 following the grant date (over three years) and convert to stock upon vesting, subject to tax withholding.
Context
These awards are standard equity compensation and do not involve an immediate cash purchase or sale. Performance rights depend on meeting specified performance metrics before converting to shares, while RSUs vest over time; neither represents a realized sale or open-market buy at grant. Such grants are routine for executive compensation and should be interpreted as part of ongoing pay programs rather than a direct signal of trading intent.
Insider Transaction Report
- Award
Performance Rights
[F1]2026-03-01+7,573→ 7,573 totalExp: 2029-02-28→ Common Stock (7,573 underlying) - Award
Restricted Stock Units
[F2]2026-03-01+5,049→ 5,049 totalExp: 2028-03-15→ Common Stock (5,049 underlying)
- 11,767
Common Stock
Footnotes (2)
- [F1]Each performance right represents a contingent right to receive one share of Visteon common stock. The vesting of the performance right is based on relative shareholder return and return on invested capital metrics over a three year performance period and payable in stock, subject to tax withholding.
- [F2]Restricted Stock Units vest to the extent of 33% of the units granted on the following March 15th of each year after the date of grant. Each Restricted Stock Unit will be converted and distributed to me, without payment, in stock upon vesting and based upon the then current market value of a share of Visteon common stock, subject to tax withholding.